![Dominik Schumacher](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenienza dei contatti di primo grado di Dominik Schumacher
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Tubulis GmbH
![]() Tubulis GmbH Pharmaceuticals: MajorHealth Technology Tubulis GmbH engages in biotechnology company. The firm develops matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology. The company was founded by Dominik Schumacher and Jonas Helma-Smets and is headquartered in Munich, Germany.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Dominik Schumacher tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
University of Copenhagen | College/University | Doctorate Degree | |
Swiss Federal Institute of Technology | College/University | Doctorate Degree | |
International Institute for Management Development | College/University | Masters Business Admin | |
Kymab Ltd.
![]() Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer | |
Vitrolife A/S
![]() Vitrolife A/S Industrial MachineryProducer Manufacturing Part of Vitrolife AB, Vitrolife A/S is a Danish company that manufactures laboratory equipment and customizes software. The company is based in Aarhus, Denmark. Kjær Andreasen has been the CEO of the company since 2014. Vitrolife was acquired by Vitrolife AB on November 26, 2014 for $84.11 million. | Industrial Machinery | Director/Board Member | |
Kongeriget Danmarks Hesteforsikring G/S
![]() Kongeriget Danmarks Hesteforsikring G/S Multi-Line InsuranceFinance Kongeriget Danmarks Hesteforsikring G/S specializes in providing horse insurance tailored to meet the needs of horse owners. The private company is based in Copenhagen, Denmark. With over 160 years of experience in specialized horse insurance, the Danish company offers greater security and peace of mind for both the owner and the horse. | Multi-Line Insurance | Director/Board Member | |
Polyneuron Pharmaceuticals AG
![]() Polyneuron Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Polyneuron Pharmaceuticals AG develops drugs for the treatment of autoimmune disorders. It develops drugs for the treatment of anti-MAG neuropathy disease and multifocal motor neuropathy disease. The firm also develops antibody-catch, a platform technology that enables the development of drugs for highly specific interception of autoimmune disease antibodies and focuses on autoimmune diseases of the peripheral nervous system that involve autoantibodies against carbohydrate epitopes. The company was founded by Andreas J. Steck, Beat Ernst, Pascal Hänggi and Ruben Herrendorffin in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Freeline Therapeutics Ltd.
![]() Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Inositec AG
![]() Inositec AG Pharmaceuticals: MajorHealth Technology Inositec AG develops small molecules as alternatives to antibiotics. It also develops a non-antibiotic small molecule that neutralizes the toxins secreted by clostridium toxins. The company was founded by Mattias Ivarsson, Bastien Castagner and Jean-Christophe Leroux in December 2015 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Chairman | |
Scenic Biotech BV
![]() Scenic Biotech BV Miscellaneous Commercial ServicesCommercial Services Scenic Biotech BV is using genomics to develop innovative therapies for patients affected by severe diseases. The company was founded by Thijn Brummelkamp and Sebastian Nijman and is headquartered in Amsterdam, Netherlands. | Miscellaneous Commercial Services | Director/Board Member | |
SNIPR Biome ApS
![]() SNIPR Biome ApS Pharmaceuticals: MajorHealth Technology SNIPR Biome ApS develops bacterial composition to provide treatment for diabetes to cancer. The company was founded by Christian Grøndal and is headquartered in Kongens Lyngby, Denmark. | Pharmaceuticals: Major | Chief Executive Officer | |
LimmaTech Biologics AG
![]() LimmaTech Biologics AG Miscellaneous Commercial ServicesCommercial Services LimmaTech Biologics AG is a clinical stage biopharmaceutical company based in Schlieren, Switzerland. LimmaTech Biologics is dedicated to combating the antimicrobial resistance epidemic by developing vaccines using its proprietary self-adjuvanting and multi-antigen vaccine platform, alongside additional disease-specific vaccine approaches. The Swiss company has decades of expertise and an expanding pipeline, and is focused on generating protective solutions to deliver transformative value worldwide. The company was founded in 2015 by Philippe Dro, Michael Wacker, Paul Wolfarm, Michael Kowarik, Veronica Gambillara Fonck. Franz-Werner Haas has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Founder |
Statistiche
Distribuzione geografica
Danimarca | 7 |
Svizzera | 7 |
Regno Unito | 3 |
Finlandia | 2 |
Paesi Bassi | 2 |
Settori
Health Technology | 9 |
Consumer Services | 4 |
Commercial Services | 3 |
Technology Services | 2 |
Producer Manufacturing | 2 |
Posizioni
Director/Board Member | 10 |
Founder | 4 |
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 3 |
Chairman | 3 |
Contatti più connessi
- Borsa valori
- Insiders
- Dominik Schumacher
- Connessioni Società